Clinical Trial Update: Tailored Regimens of PEGASYS® and Ribavirin for Genotype 1 Chronic Hepatitis C Patients Trial (TARGET-1) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on tailored regimens of PEGASYS and ribavirin for genotype 1 chronic hepatitis C, now completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Pegasys (pegylated interferon alfa-2a)
• Ribavirin (ribavirin)

Snippet

Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital | Conditions: Hepatitis C | Phase 4 | Status: COMPLETED